Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
14,545.00    -40.00 (-0.27%)
Bid:
14,545.00
Ask:
14,555.00
Spread: 10.00 (0.069%)
Market Cap: £16.60b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

AGM Update

13 Nov 2023 12:30

RNS Number : 2647T
Next PLC
13 November 2023
Β 

13 November 2023

Β 

NEXT plc ("the Company" or "NEXT")

Β 

AGM Update

All resolutions put to shareholders at the NEXT 2023 Annual General Meeting ("the AGM") on 18 May 2023 were passed. A minority (20.84%) of shareholders that voted, chose not to support resolution 12 which related to the re-election of the Company's Non-Executive Chair, Mr. Michael Roney, as a director of the Company.

Β 

In line with the provisions of the 2018 UK Corporate Governance Code, the Company engaged in a consultation process with shareholders to gain an understanding of their reasons for voting against the re-election of Mr. Roney and now provides this update on the views received from shareholders.

Β 

Based on the views expressed by those shareholders before the AGM and who were identified as having voted against and who responded to the consultation, the level of votes against Mr. Roney's re-election were primarily due to him being considered as overboarded with a secondary concern relating to the gender make up of the Board.

Β 

The Board accepts that some investors apply a stricter voting policy than the market generally in relation to Chair and Directorship roles on the boards of listed companies. Mr. Roney provides more than enough time to his role as Chair and effectively discharges the functions and obligations of the role. He has attended all Board and Committee meetings held in the past three years. He is always available when required as was evident in the Group's response to the pandemic and his involvement in the major strategic decisions made by the Board in recent years.

Β 

The NEXT Nomination Committee monitors Directors' external commitments and would take appropriate action in the event of any concerns being raised about the ability of any director, including the Chair, to dedicate sufficient time to their roles.

Β 

Mr. Roney brings significant experience to his role at NEXT, provides clear direction and leadership to the Board and the Board believes that his continuing appointment as Chair is for the benefit of all stakeholders in the Company.

Β 

The Company will set out further details on these matters in the 2024 Annual Report.

Β 

Β 

Ian Blackwell

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMGPGWPGUPWGPW
Date   Source Headline
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights
12th Jul 20235:08 pmRNSTransaction in Own Shares
11th Jul 20235:46 pmRNSTransaction in Own Shares
10th Jul 20235:14 pmRNSTransaction in Own Shares
7th Jul 20235:10 pmRNSTransaction in Own Shares
6th Jul 20235:44 pmRNSTransaction in Own Shares
5th Jul 20235:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.